V. Montori, M. Bhandari, and P. Devereaux, In the dark The reporting of blinding status in randomized controlled trials, Journal of Clinical Epidemiology, vol.55, issue.8, pp.787-90, 2002.
DOI : 10.1016/S0895-4356(02)00446-8

L. Wood, M. Egger, and L. Gluud, Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study, BMJ, vol.336, issue.7644, pp.601-606, 2008.
DOI : 10.1136/bmj.39465.451748.AD

K. Schulz and D. Grimes, Blinding in randomised trials: hiding who got what, The Lancet, vol.359, issue.9307, pp.696-700, 2002.
DOI : 10.1016/S0140-6736(02)07816-9

I. Boutron, C. Estellat, and L. Guittet, Methods of Blinding in Reports of Randomized Controlled Trials Assessing Pharmacologic Treatments: A Systematic Review, PLoS Medicine, vol.330, issue.10, p.425, 2006.
DOI : 10.1371/journal.pmed.0030425.sd001
URL : https://hal.archives-ouvertes.fr/inserm-00128342

*. Boutron, I. Guittet, L. Estellat, and C. , Reporting Methods of Blinding in Randomized Trials Assessing Nonpharmacological Treatments, PLoS Medicine, vol.330, issue.2, p.61, 2007.
DOI : 10.1371/journal.pmed.0040061.st003
URL : https://hal.archives-ouvertes.fr/inserm-00166560

S. Hollis and F. Campbell, What is meant by intention to treat analysis? Survey of published randomised controlled trials, BMJ, vol.319, issue.7211, pp.670-674, 1999.
DOI : 10.1136/bmj.319.7211.670

S. Heritier, V. Gebski, and A. Keech, Inclusion of patients in clinical trial analysis: the intention-to-treat principle, Med J Aust, vol.179, pp.438-478, 2003.

K. Bergholdt, R. Fabricius, and T. Bendix, Better backs by better beds? Spine, pp.703-711, 2008.
DOI : 10.1097/brs.0b013e3181695d3b

G. Baron, I. Boutron, and B. Giraudeau, Violation of the intent-to-treat principle and rate of missing data in superiority trials assessing structural outcomes in rheumatic diseases, Arthritis & Rheumatism, vol.55, issue.6, pp.1858-65, 2005.
DOI : 10.1002/art.21116

J. Weinstein, T. Tosteson, and J. Lurie, Surgical vs Nonoperative Treatment for Lumbar Disk Herniation, JAMA, vol.296, issue.20, pp.2441-50, 2006.
DOI : 10.1001/jama.296.20.2441

M. Kyriakidi and J. Ioannidis, Design and quality considerations for randomized controlled trials in systemic sclerosis, Arthritis & Rheumatism, vol.354, issue.1, pp.73-81, 2002.
DOI : 10.1002/art1.10218

T. Fleming and D. Demets, Surrogate end points in clinical trials: are we being misled? Ann Intern Med, pp.605-618, 1996.

B. Riggs, S. Hodgson, O. Fallon, and W. , Effect of Fluoride Treatment on the Fracture Rate in Postmenopausal Women with Osteoporosis, New England Journal of Medicine, vol.322, issue.12, pp.802-811, 1990.
DOI : 10.1056/NEJM199003223221203

A. Chan, A. Hrobjartsson, M. Haahr, P. Gotzsche, and D. Altman, Empirical Evidence for Selective Reporting of Outcomes in Randomized Trials, JAMA, vol.291, issue.20, pp.2457-65, 2004.
DOI : 10.1001/jama.291.20.2457

*. Rothwell and P. , Subgroup analysis in randomised controlled trials: importance, indications, and interpretation, The Lancet, vol.365, issue.9454, pp.176-86, 2005.
DOI : 10.1016/S0140-6736(05)17709-5

*. Cook, R. Sackett, and D. , The number needed to treat: a clinically useful measure of treatment effect, BMJ, vol.310, issue.6977, pp.452-456, 1995.
DOI : 10.1136/bmj.310.6977.452

M. Osiri, M. Suarez-almazor, and G. Wells, Number needed to treat (NNT): implication in rheumatology clinical practice, Annals of the Rheumatic Diseases, vol.62, issue.4, pp.316-337, 2003.
DOI : 10.1136/ard.62.4.316

A. Laupacis, D. Sackett, and R. Roberts, An Assessment of Clinically Useful Measures of the Consequences of Treatment, New England Journal of Medicine, vol.318, issue.26, pp.1728-1761, 1988.
DOI : 10.1056/NEJM198806303182605

H. Keen, K. Pile, and C. Hill, The prevalence of underpowered randomized clinical trials in rheumatology, J Rheumatol, vol.32, pp.2083-2091, 2005.

G. Guyatt, E. Mills, and D. Elbourne, In the Era of Systematic Reviews, Does the Size of an Individual Trial Still Matter?, PLoS Medicine, vol.7, issue.1, p.4, 2008.
DOI : 0098-7484(2005)294[2203:RTSEFB]2.0.CO;2

D. Altman and J. Bland, Statistics Notes: Units of analysis, BMJ, vol.314, issue.7098, p.1874, 1997.
DOI : 10.1136/bmj.314.7098.1874

S. Bolton, Independence and Statistical Inference in Clinical Trial Designs: A Tutorial Review, The Journal of Clinical Pharmacology, vol.23, issue.5, pp.408-420, 1998.
DOI : 10.1002/j.1552-4604.1998.tb04444.x

*. Rothwell and P. , External validity of randomised controlled trials: ???To whom do the results of this trial apply????, The Lancet, vol.365, issue.9453, pp.82-93, 2005.
DOI : 10.1016/S0140-6736(04)17670-8